Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells

por Salman, Huda, Pinz, Kevin G., Wada, Masayuki, Shuai, Xiao, Yan, Lulu E., Petrov, Jessica C., Ma, Yupo
Publicado 2019

Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia

por Petrov, Jessica C., Wada, Masayuki, Pinz, Kevin G., Yan, Lulu E., Chen, Kevin H., Shuai, Xiao, Liu, Hua, Chen, Xi, Leung, Lai-Han, Salman, Huda, Hagag, Nabil, Liu, Fang, Jiang, Xun, Ma, Yupo
Publicado 2018